We observed that treatment with Roscovitine significantly decreased PD-L1 expression in both circulating (Figures 4A–C) and tumor-infiltrating (Figures 4D, E) MDSC subsets compared to vehicle controls. This evidence concerns the gene CD274 and neoplasm.